NCT02706379

Brief Summary

Early goal directed therapy (EGDT) is an effective treatment for patients with septic shock, which is widely used in clinic. Fluid resuscitation can significantly reduce the mortality of patients with septic shock and improve the prognosis of patients with EGDT. However, in recent years, the standard of EGDT to determine the existence of the target of septic shock. Some studies have shown that there may be a manifestation of the deficiency of kidney and liver and other organs such as kidney, liver and other organs in the recovery of EGDT. Therefore, this experiment is to explore the brain perfusion and metabolism of the EGDT when the target is reached.The aim of this study was to investigate the effects of EGDT as a guide to the cerebral perfusion and metabolism in order to provide clinical evidence for the treatment of fluid resuscitation in patients with septic shock.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
26

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jun 2015

Shorter than P25 for not_applicable

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2015

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

December 11, 2015

Completed
3 months until next milestone

First Posted

Study publicly available on registry

March 11, 2016

Completed
21 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2016

Completed
Last Updated

March 11, 2016

Status Verified

February 1, 2016

Enrollment Period

10 months

First QC Date

December 11, 2015

Last Update Submit

March 7, 2016

Conditions

Outcome Measures

Primary Outcomes (1)

  • change of local cerebral oxygen saturation between early goal directed treatment(EGDT)

    Test the local cerebral oxygen saturation of both sides of brain through near infrared spectroscopy technology. And record the change of local cerebral oxygen of the left and right's brain.

    through study completion, up to 6 hours

Secondary Outcomes (2)

  • change of neuron specific enolase(NSE)

    through study completion, up to 6 hours

  • change of S-100 protein

    through study completion, up to 6 hours

Study Arms (1)

Local cerebral oxygen saturation

EXPERIMENTAL

use NIRS technical to detect local cerebral oxygen saturation of both sides of brain

Other: Local cerebral oxygen saturation

Interventions

take blood culture before antibiotic use;measure the blood lactate;liquid rescisutation as 20ml/kg

Local cerebral oxygen saturation

Eligibility Criteria

Age19 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • New infectious shock in accordance with the diagnostic criteria of the 2012 SSC guidelines;
  • Liquid recovery is not fully achieved EGDT standards, at least meet the following criteria:
  • mean arterial pressure \< 65mmHg
  • central venous pressure \< 8mmHg
  • per hour urine volume was less than 0.5ml/kg
  • central venous oxygen saturation \<70%
  • arterial blood lactic acid value \> 2.5mmol/L
  • Signed informed consent

You may not qualify if:

  • Subjects/subjects client reject the invasive hemodynamic monitoring
  • have contraindications to place hemodynamic monitoring
  • unconsciousness state before septic shock and GCS\<12
  • cannot put the electrodes on the eyebrow
  • pregnant or lactating women
  • end stage of illness or death rate is more than 80%

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Shock, Septic

Condition Hierarchy (Ancestors)

SepsisInfectionsSystemic Inflammatory Response SyndromeInflammationPathologic ProcessesPathological Conditions, Signs and SymptomsShock

Study Officials

  • Haibo Qiu, Doctor

    13951965301

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
director

Study Record Dates

First Submitted

December 11, 2015

First Posted

March 11, 2016

Study Start

June 1, 2015

Primary Completion

April 1, 2016

Study Completion

April 1, 2016

Last Updated

March 11, 2016

Record last verified: 2016-02

Data Sharing

IPD Sharing
Will not share

The data is personal, and will not share to others.